Reversible increase of GGT induced by levetiracetam as an add-on drug;Reversibler GGT-anstieg bei einer levetiracetam-kombinationstherapie

Aktuelle Neurologie

Volumn 32, Issue 9, 2005, Pages 537-540

  Fröscher, Walter ^a,b   Raape, J ^a   Rosche J ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Abteilung Neurologie/Epileptologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTICONVULSIVE AGENT; CALCIUM; DIAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FUROSEMIDE; GAMMA GLUTAMYLTRANSFERASE; HYDROCHLOROTHIAZIDE; LAMOTRIGINE; METOPROLOL; PRIMIDONE; RAMIPRIL; SPIRONOLACTONE; TOPIRAMATE; TRIAMTERENE; VALPROIC ACID; VITAMIN D; ZOPICLONE;

ADD ON THERAPY; AGED; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EPILEPSY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LIVER DYSFUNCTION; MALE; POSTMARKETING SURVEILLANCE; RARE DISEASE;

EID: 29144469078     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-866928     Document Type: Article

References (13)

1. Gavilán JC, Bermúdez F, Romero M, y Santos PG. Hepatitis por levetiracetam. Med Clin (Barc) 2004; 122: 38
2. Krämer G, Edrich P. Efficacy and safety of levetiracetam in the elderly. Poster. Annual meeting of the American Epilepsy Society, Philadelphia (USA), 30 Nov-5 Dez 2001. Epilepsia 2001; 42, Suppl 7: 142-143
3. Harden C. Safety profile of levetiracetam. Epilepsia 2001; 42: 36-39
4. Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet 2004; 43: 707-724
5. Bartels H, Evert W, Hauck W et al. Significance of increased serum gamma-glutamyl-transferase activity during long-term anticonvulsive treatment. Clinical and experimental studies. Neuropädiatrie 1975; 6: 77-89
6. Rambeck B, May TW. Enzyminduktion in der Leber durch Antiepileptika. In: Fröscher W, Blankenhorn V, May TW et al (Hrsg): Pharmakotherapie der Epilepsien, 3. Aufl. Stuttgart: Schattauer, 2000: 127-130
7. Keppra®-Fachinformation. Kerpen: UCB GmbH, Oktober 2004
8. Patsalos PN, Fröscher W, Pisani F, Rijn C van. The importance of drug interactions in epilepsy therapy. Epilepsia 2002; 43: 365-385
9. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. The Lancet Neurology 2003; 2: 347-356
10. Stölzel U, Teubner A, Ernstberger J et al. Isolierte Erhöhung der GGT: Was ist diagnostisch erforderlich? Dtsch Med Wochenschr 2004; 129: S54-S56
11. Thomas L. Labor und Diagnose. 5. Aufl. Frankfurt/Main: TH-Books-Verlagsgesellschaft, 1998
12. th Epilepsy Internat. Symp. New York: Raven Press, 1983: 263-272
13. Swann AC. Major system toxicities and side effects of anticonvulsants. J Clin Psychiatry 2001; 62, Suppl 14: 16-21